Abstract:Background: Patients with type 2 diabetes mellitus (T2DM) face an increased risk of developing depression and metabolic dysregulation, which can lead to a higher risk of cardiovascular disease (CVD). However, the relationship between the severity of depression and metabolic dysregulation in patients with T2DM remains unclear. This study aimed to investigate this association using data from the ACCORD‐health‐related quality of life study. Methods and Results: Patient Health Questionnaire‐9 (PHQ‐9) scores and medication regimens were assessed at baseline, 1, 3, and 4 years, and HbA1c, blood pressure, and lipid levels were monitored every 4 months over a 4‐year period. The severity of depressive symptoms was categorized as none (0–4 points), mild (5–9 points), or moderate–severe (10–24 points) based on PHQ‐9 scores. Among the participants, 62% developed depressive symptoms at some point during the 4‐year follow‐up period, with 21% experiencing persistent depressive symptoms. Participants with moderate‐to‐severe depression exhibited 0.18% (0.12, 0.24) higher levels of HbA1c, 1.11 mmHg (95% CI, 0.04, 2.15) of SBP, 0.90 mmHg (95% CI, 0.22,1.58) of DBP, and 2.12(95% CI, −0.03, 4.27) mg/dL of LDL, and 0.97 (95% CI, 0.38, 1.56) mg/dL lower levels of HDL compared to their counterparts without depressive symptoms. Moreover, as the severity of depressive symptoms increased, variability in HbA1c and blood pressure levels also increased. Furthermore, patients with more severe depressive symptoms demonstrated suboptimal adherence to medication regimens. Conclusion: Our study found a significant association between depressive symptoms severity and metabolic control in T2DM patients. Greater depressive severity correlated with poorer glycemic, blood pressure, and lipid control, alongside increased variability in these parameters. Additionally, patients with severe depressive symptoms showed suboptimal medication adherence. Addressing mental health in T2DM management is crucial to improve metabolic control and reduce CVD risks. Trial Registration: ClinicalTrials.gov identifier: NCT00000620

The impact of major depressive disorder on glycaemic control in type 2 diabetes: a longitudinal cohort study using UK Biobank primary care records

Prospective Study of Depressive Symptoms and Incident Cardiovascular Diseases in People with Type 2 Diabetes

The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes

Factors associated with the onset of major depressive disorder in adults with type 2 diabetes living in 12 different countries: results from the INTERPRET-DD prospective study

Impact of Major Depressive Disorder on Prediabetes by Impairing Insulin Sensitivity

Early and ongoing stable glycaemic control is associated with a reduction in major adverse cardiovascular events in people with type 2 diabetes: A primary care cohort study

Longitudinal Changes in Depression Symptoms and Glycemia in Adults With Type 1 Diabetes

Depressive Symptoms and Metabolic Dysregulation Control: A Closer Look at Control Challenges in T2DM Patients

Associations between body weight change and incidence of major depressive disorder in patients with type 2 diabetes mellitus: a nationwide longitudinal follow-up cohort study of 1.1 million

Association between type 2 diabetes and depressive symptoms after a 1-year follow-up in an older adult Mediterranean population

Eight-year nationwide study of the bidirectional association between type 2 diabetes and depression in nearly 8 million German outpatients

Depression in Type 2 Diabetes Mellitus: Prevalence, Impact, and Treatment

Association between mental health comorbidity and health outcomes in type 2 diabetes mellitus patients

Association between depression with glycemic control and its complications in type 2 diabetes

Diabetes Control Status and Severity of Depression: Insights from NHANES 2005–2020

Population-Based Cohort Analyses of the Bidirectional Relationship Between Type 2 Diabetes and Depression

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

Joint Exposure to Positive Affect, Life Satisfaction, Depressive Symptoms, and Neuroticism and Incident Type 2 Diabetes

A longitudinal study of healthcare utilisation and expenditure in people with type 2 diabetes mellitus with and without major depressive disorder

Treatment for comorbid depressive disorder or subthreshold depression in diabetes mellitus: Systematic review and meta‐analysis